Japanese CRO JCL Bioassay To Go Public On Osaka Stock Exchange
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Japan Clinic Laboratories Bioassay, a clinical and non-clinical trial contract drug concentration testing company, will go public March 17. The company shares will be listed on Osaka Stock Exchange's Hercules Market. JCL Bioassay plans to invest the raised funds in establishing a research institute in the U.S. (Click here for more - Japanese language